Pharmacodynamics and Pharmacokinetics of Two Dose Regimens of Befloxatone, a New Reversible and Selective Monoamine Oxidase Inhibitor, at Steady State in Healthy Volunteers-Reference-Cited by-同舟云学术

Pharmacodynamics and Pharmacokinetics of Two Dose Regimens of Befloxatone, a New Reversible and Selective Monoamine Oxidase Inhibitor, at Steady State in Healthy Volunteers

Published:1996-03 Issue:3 Volume:36 Page:216-229
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Patat Alain,le Coz Franck,Dubruc Catherine,Gandon Jean-Marc,Durrieu Geneviève,Cimarosti Isabelle,Jezequel Sylvie,Curet Olivier,Zieleniuk Isabelle,Allain Hervé,Rosenzweig Pierre

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference42 articles.

1. The present status of monoamine oxidase inhibitors;Pare;Br J Psychiatry,1985

2. Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs;Blackwell;Br J Psychiatry,1967

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacodynamics of norepinephrine reuptake inhibition: Modeling the peripheral and central effects of atomoxetine, duloxetine, and edivoxetine on the biomarker 3,4-dihydroxyphenylglycol in humans;The Journal of Clinical Pharmacology;2015-07-29

2. Understanding the Hysteresis Loop Conundrum in Pharmacokinetic / Pharmacodynamic Relationships;Journal of Pharmacy & Pharmaceutical Sciences;2014-03-10

3. Unique pentafluorobenzylation and collision-induced dissociation for specific and accurate GC–MS/MS quantification of the catecholamine metabolite 3,4-dihydroxyphenylglycol (DHPG) in human urine;Journal of Chromatography B;2011-05

4. Clinical Pharmacology Tyramine Challenge Study to Determine the Selectivity of the Monoamine Oxidase Type B (MAO-B) Inhibitor Rasagiline;The Journal of Clinical Pharmacology;2010-12

5. Biomarkers and Surrogate Markers in Drug Development;Critical Pathways to Success in CNS Drug Development;2010-03-05